-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Annamycin in Synovial Sarcoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Annamycin in Synovial Sarcoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Annamycin in Synovial SarcomaDrug Details:L-Annamycin is under development for the treatment of relapsed...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Clobetasol Propionate in Ocular Pain (Eye Pain)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Clobetasol Propionate in Ocular Pain (Eye Pain) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Clobetasol Propionate in Ocular Pain (Eye Pain)Drug Details:clobetasol propionate is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Clotrimazole in Otitis Externa
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Clotrimazole in Otitis Externa report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Clotrimazole in Otitis ExternaDrug Details:clotrimazole (SVT-15652) is under development for the treatment of...
-
Product Insights
Glucose Monitoring Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Glucose Monitoring Pipeline Market Report Overview Glucose monitoring devices are used for time-defined or continuous measurement of blood glucose. Glucose monitoring does not include devices for ketone body testing or of any other blood constituents other than glucose. The Glucose Monitoring pipeline market research report provides comprehensive information about the Glucose Monitoring pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. Key Segments ·      Continuous...
-
Company Profile
EnQuest Plc – Company Profile
EnQuest Plc (EnQuest) is an independent oil and gas exploration and production company. The company carries out operational and redevelopment interests in onshore and offshore oil and gas fields in the UK North Sea and Malaysia. Its operated assets include Thistle and Deveron, Heather and Broom, the Dons area, Magnus, the Greater Kittiwake area, Scolty and Crathes, Alma and Galia, Kraken, PM8 and Seligi and PM409 production sharing contracts. The company also owns interest in Alba, a non-operated oil producing...
Add to Basket -
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – SVT-4A1011
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry SVT-4A1011 Drug Details SVT-4A1011 is under development for the treatment of insomnia. The therapeutic...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – SVT-15652
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry SVT-15652 Drug Details SVT-15652 is under development for the treatment of fungal otitis externa...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – SVT-11652
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry SVT-11652 Drug Details SVT-11652 is under development for the treatment of acute otitis externa....
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – SVT-15435
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry SVT-15435 Drug Details SVT-15435 is under development for the treatment of glaucoma. The drug...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – SVT-18412
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry SVT-18412 Drug Details SVT-18412 is under development for the treatment of glaucoma. The therapeutic...